Fig. 1

Expression analysis of PGK1 in NSCLC tissues and cell lines. a Comparison of PGK1 mRNA expression in NSCLC samples and normal samples using the TCGA and GTEx databases. b Differential mRNA expression of PGK1 between NSCLC tissues and normal tissues based on the GENT2 database. c Assessment of PGK1 mRNA levels in tumors and normal tissues of NSCLC patients from the GEO database. d PGK1 mutations and copy number alterations in NSCLC tissues examined by the cBioPortal database. e The protein levels of PGK1 in various normal and tumor tissues from the CPTAC database. f PGK1 protein expression across different tumor tissues in the HPA database. g The mRNA expression of PGK1 in tumor cell lines from the CCLE database. h Identification of PGK1 mRNA expression in NSCLC cells using qRT-PCR. (i) The association between PGK1 mRNA expression and tumor stage by analyzing the TCGA dataset. (j) The mRNA levels of PGK1 in primary and metastatic NSCLC specimens from the TCGA cohort. ^*P < 0.05, ^**P < 0.01, ^***P < 0.001, and ns, not significant